📌 𝗪𝗵𝗮𝘁'𝘀 𝗡𝗲𝘄 𝗶𝗻 𝗗𝗶𝗮𝗯𝗲𝘁𝗲𝘀 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 - 𝟮𝟬𝟮𝟱 𝗔𝗗𝗔 𝗚𝘂𝗶𝗱𝗲𝗹𝗶𝗻𝗲?

Dear Doctors, Now, it is time to kindly present the academic insights of Dr. Kyar Nyo Soe Myint on: ✅ “Comprehensive Medical Evaluation and Assessment of Comorbidities” • Metabolic-Associated Steatotic Liver Disease (MASLD) • Metabolic-Associated Steatohepatitis (MASH) ✅ “Children and Adolescents” and ✅ “Older Adults” 📌 This program is organized by the Myanmar Diabetes Association (MMDA) and the Myanmar Society of Endocrinology and Metabolism (MSEM). 💊This program is proudly supported by 𝗭𝗶𝗴𝗹𝗶𝗽 𝟱𝟬 & 𝟭𝟬𝟬 (𝗦𝗶𝘁𝗮𝗴𝗹𝗶𝗽𝘁𝗶𝗻 𝟱𝟬 𝗺𝗴 & 𝟭𝟬𝟬 𝗺𝗴) 𝗮𝗻𝗱 𝗘𝗺𝗳𝗹𝗼𝘇𝗶𝗻 𝟭𝟬 & 𝟮𝟱 (𝗘𝗺𝗽𝗮𝗴𝗹𝗶𝗳𝗹𝗼𝘇𝗶𝗻 𝟭𝟬 𝗺𝗴 & 𝟮𝟱 𝗺𝗴). #ADA #StandardsofCare #ADAguideline #Recommendations #Diabetes #Hyperglycemia #Obesity #WeightManagement #MASLD #MASH #CardiovascularDisease #GlycemicGoals #Renal #MSEM #MMDA #Ziglip #Sitagliptin #Emflozin #Empagliflozin #myanmardiabetesassociationmmda